Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Mycobacterial heat shock protein 65 mediated metabolic shift in decidualization of human endometrial stromal cells.

Subramani E, Rameshbabu AP, Jothiramajayam M, Subramanian B, Chakravorty D, Bose G, Joshi M, Ray CD, Lodh I, Chattopadhyay R, Saha S, Mukherjee A, Dhara S, Chakravarty B, Chaudhury K.

Sci Rep. 2017 Jun 21;7(1):3942. doi: 10.1038/s41598-017-04024-w.

2.

Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients.

Battini S, Faitot F, Imperiale A, Cicek AE, Heimburger C, Averous G, Bachellier P, Namer IJ.

BMC Med. 2017 Mar 16;15(1):56. doi: 10.1186/s12916-017-0810-z.

3.

Near infrared fluorescent imaging of choline kinase alpha expression and inhibition in breast tumors.

Arlauckas SP, Kumar M, Popov AV, Poptani H, Delikatny EJ.

Oncotarget. 2017 Mar 7;8(10):16518-16530. doi: 10.18632/oncotarget.14965.

4.

Targeting Phospholipid Metabolism in Cancer.

Cheng M, Bhujwalla ZM, Glunde K.

Front Oncol. 2016 Dec 27;6:266. doi: 10.3389/fonc.2016.00266. eCollection 2016. Review.

5.

The Tumor Microenvironment Modulates Choline and Lipid Metabolism.

Mori N, Wildes F, Takagi T, Glunde K, Bhujwalla ZM.

Front Oncol. 2016 Dec 22;6:262. doi: 10.3389/fonc.2016.00262. eCollection 2016.

6.

Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma.

Hu L, Wang RY, Cai J, Feng D, Yang GZ, Xu QG, Zhai YX, Zhang Y, Zhou WP, Cai QP.

Oncotarget. 2016 Oct 11;7(41):66660-66678. doi: 10.18632/oncotarget.11433.

7.

Human Choline Kinase-α Promotes Hepatitis C Virus RNA Replication through Modulation of Membranous Viral Replication Complex Formation.

Wong MT, Chen SS.

J Virol. 2016 Sep 29;90(20):9075-95. doi: 10.1128/JVI.00960-16. Print 2016 Oct 15.

8.

Choline Metabolism Alteration: A Focus on Ovarian Cancer.

Bagnoli M, Granata A, Nicoletti R, Krishnamachary B, Bhujwalla ZM, Canese R, Podo F, Canevari S, Iorio E, Mezzanzanica D.

Front Oncol. 2016 Jun 22;6:153. doi: 10.3389/fonc.2016.00153. eCollection 2016. Review.

9.

Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC).

Tang Z, Shen Q, Xie H, Zhou X, Li J, Feng J, Liu H, Wang W, Zhang S, Ni S.

Oncotarget. 2016 Jul 19;7(29):46253-46262. doi: 10.18632/oncotarget.10086.

10.

The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth.

Trousil S, Kaliszczak M, Schug Z, Nguyen QD, Tomasi G, Favicchio R, Brickute D, Fortt R, Twyman FJ, Carroll L, Kalusa A, Navaratnam N, Adejumo T, Carling D, Gottlieb E, Aboagye EO.

Oncotarget. 2016 Jun 14;7(24):37103-37120. doi: 10.18632/oncotarget.9466.

11.

Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.

Arlauckas SP, Popov AV, Delikatny EJ.

Prog Lipid Res. 2016 Jul;63:28-40. doi: 10.1016/j.plipres.2016.03.005. Epub 2016 Apr 9. Review.

PMID:
27073147
12.

Metformin Decouples Phospholipid Metabolism in Breast Cancer Cells.

Smith TA, Phyu SM.

PLoS One. 2016 Mar 9;11(3):e0151179. doi: 10.1371/journal.pone.0151179. eCollection 2016.

13.

Increased activity of CHK enhances the radioresistance of MCF-7 breast cancer stem cells.

Yang ZX, Sun YH, He JG, Cao H, Jiang GQ.

Oncol Lett. 2015 Dec;10(6):3443-3449. Epub 2015 Oct 2.

14.

Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target.

Asim M, Massie CE, Orafidiya F, Pértega-Gomes N, Warren AY, Esmaeili M, Selth LA, Zecchini HI, Luko K, Qureshi A, Baridi A, Menon S, Madhu B, Escriu C, Lyons S, Vowler SL, Zecchini VR, Shaw G, Hessenkemper W, Russell R, Mohammed H, Stefanos N, Lynch AG, Grigorenko E, D'Santos C, Taylor C, Lamb A, Sriranjan R, Yang J, Stark R, Dehm SM, Rennie PS, Carroll JS, Griffiths JR, Tavaré S, Mills IG, McEwan IJ, Baniahmad A, Tilley WD, Neal DE.

J Natl Cancer Inst. 2015 Dec 11;108(5). doi: 10.1093/jnci/djv371. Print 2016 May.

15.

Molecular Imaging of Prostate Cancer.

Wibmer AG, Burger IA, Sala E, Hricak H, Weber WA, Vargas HA.

Radiographics. 2016 Jan-Feb;36(1):142-59. doi: 10.1148/rg.2016150059. Epub 2015 Nov 20. Review.

16.

Magnetic Resonance Spectroscopy of siRNA-Based Cancer Therapy.

Penet MF, Chen Z, Mori N, Krishnamachary B, Bhujwalla ZM.

Methods Mol Biol. 2016;1372:37-47. doi: 10.1007/978-1-4939-3148-4_3.

17.

Downregulation of Choline Kinase-Alpha Enhances Autophagy in Tamoxifen-Resistant Breast Cancer Cells.

Kim HS, Tian L, Jung M, Choi SK, Sun Y, Kim H, Moon WK.

PLoS One. 2015 Oct 23;10(10):e0141110. doi: 10.1371/journal.pone.0141110. eCollection 2015.

18.
19.

Choline metabolism-based molecular diagnosis of cancer: an update.

Glunde K, Penet MF, Jiang L, Jacobs MA, Bhujwalla ZM.

Expert Rev Mol Diagn. 2015 Jun;15(6):735-47. doi: 10.1586/14737159.2015.1039515. Epub 2015 Apr 28. Review.

20.

¹H NMR based serum metabolic profiles associated with pathological progression of pancreatic islet β cell tumor in Rip1-Tag2 mice.

Yang Y, Liu Y, Zheng L, Zhang Q, Gu Q, Wang L, Wang L.

Int J Biol Sci. 2015 Apr 5;11(5):595-603. doi: 10.7150/ijbs.11058. eCollection 2015.

Supplemental Content

Support Center